Fifth Third Bancorp
FBRX

Fifth Third Bancorp’s Forte Biosciences FBRX Stock Holding History

Fifth Third Bancorp’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19K Sell
150
-346
-70% -$8.2K ﹤0.01% 4020
2026
Q1 		$12.8K Buy
+496
New +$14.3K ﹤0.01% 3632

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Fifth Third Bancorp's FBRX Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Forte Biosciences (FBRX) stake by 70% in Q2 2026, selling an estimated $8.2K and leaving 150 shares worth $3.19K. The position accounts for ﹤0.01% of the portfolio, ranked #4020.

Fifth Third Bancorp first reported a position in FBRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $12.8K in Q1 2026. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Fifth Third Bancorp held 150 shares of Forte Biosciences worth $3.19K as of Q2 2026.
  • Fifth Third Bancorp sold 346 Forte Biosciences shares in Q2 2026, an estimated $8.2K.
  • Forte Biosciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4020 holding.
  • Fifth Third Bancorp first reported a position in Forte Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Fifth Third Bancorp's Forte Biosciences position peaked at $12.8K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.